In simple terms, China Medicine Corporation has 2845.45 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.293% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.189%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.027%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.026% return, is a testament to China Medicine Corporation's adeptness in optimizing resource deployment. China Medicine Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.039%. Furthermore, the proficiency of China Medicine Corporation in capital utilization is underscored by a remarkable 0.234% return on capital employed.
Stock Prices
China Medicine Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.0001, while its low point bottomed out at $0.0001. This variance in figures offers investors a lucid insight into the roller-coaster ride that is China Medicine Corporation's stock market.
Liquidity Ratios
Analyzing CHME liquidity ratios reveals its financial health of the firm.
The current ratio of 209.90% gauges short-term asset coverage for liabilities.
The quick ratio (158.08%) assesses immediate liquidity, while the cash ratio (3.27%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
209.90%
Quick Ratio
158.08%
Cash Ratio
3.27%
Profitability Ratios
CHME profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 7.65% underscores its earnings before tax deductions.
The effective tax rate stands at 71.68%, revealing its tax efficiency.
The net income per EBT, 34.69%, and the EBT per EBIT, 40.37%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 18.94%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
7.65%
Effective Tax Rate
71.68%
Net Income per EBT
34.69%
EBT per EBIT
40.37%
EBIT per Revenue
18.94%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 2.10, it details the span from stock purchase to revenue.
The 2 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
158
Days of Inventory Outstanding
22
Operating Cycle
147.59
Days of Payables Outstanding
11
Cash Conversion Cycle
137
Receivables Turnover
2.90
Payables Turnover
34.56
Inventory Turnover
16.76
Fixed Asset Turnover
5.40
Asset Turnover
0.97
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.11, and free cash flow per share, 0.87, depict cash generation on a per-share basis.
The cash per share value, 0.03, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.26, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
1.11
Free Cash Flow per Share
0.87
Cash per Share
0.03
Operating Cash Flow Sales Ratio
0.26
Free Cash Flow to Operating Cash Flow Ratio
0.78
Cash Flow Coverage Ratio
1.78
Short Term Coverage Ratio
1.78
Capital Expenditure Coverage Ratio
4.62
Dividend Paid and Capex Coverage Ratio
4.62
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 14.22%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.21, we discern the balance between debt and equity financing.
cards.indicator
cards.value
Debt Ratio
14.22%
Debt Equity Ratio
0.21
Total Debt to Capitalization
17.44%
Cash Flow to Debt Ratio
1.78
Company Equity Multiplier
1.49
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.24, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 0.11, reflects the portion of profit attributed to each share.
The book value per share, 2.95, represents the net asset value distributed per share, while the tangible book value per share, 1.89, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
4.24
Net Income Per Share
0.11
Book Value Per Share
2.95
Tangible Book Value Per Share
1.89
Shareholders Equity Per Share
2.95
Interest Debt Per Share
0.62
Capex Per Share
-0.24
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 20.70%, indicates top-line expansion, while the gross profit growth, 21.91%, reveals profitability trends.
EBIT growth, 12.25%, and operating income growth, 12.25%, offer insights into operational profitability progression.
The net income growth, -81.18%, showcases bottom-line expansion, and the EPS growth, -81.67%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
20.70%
Gross Profit Growth
21.91%
EBIT Growth
12.25%
Operating Income Growth
12.25%
Net Income Growth
-81.18%
EPS Growth
-81.67%
EPS Diluted Growth
-81.67%
Weighted Average Shares Growth
0.62%
Weighted Average Shares Diluted Growth
0.67%
Operating Cash Flow Growth
302.92%
Free Cash Flow Growth
761.00%
10-Year Revenue Growth per Share
195.68%
5-Year Revenue Growth per Share
195.68%
3-Year Revenue Growth per Share
29.96%
10-Year Operating CF Growth per Share
216.32%
5-Year Operating CF Growth per Share
216.32%
3-Year Operating CF Growth per Share
468.17%
10-Year Net Income Growth per Share
-72.25%
5-Year Net Income Growth per Share
-72.25%
3-Year Net Income Growth per Share
-82.72%
10-Year Shareholders Equity Growth per Share
927.79%
5-Year Shareholders Equity Growth per Share
927.79%
3-Year Shareholders Equity Growth per Share
64.95%
10-Year Dividend per Share Growth per Share
-100.00%
5-Year Dividend per Share Growth per Share
-100.00%
Receivables Growth
12.57%
Inventory Growth
-42.20%
Asset Growth
49.60%
Book Value per Share Growth
4.55%
R&D Expense Growth
73.05%
SGA Expenses Growth
38.35%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 74,684,692.6, captures the company's total value, considering both debt and equity.
Income quality, 12.10, assesses the reliability of reported earnings.
The ratio of intangibles to total assets, 24.96%, indicates the value of non-physical assets, and capex to operating cash flow, -21.66%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
74,684,692.6
Income Quality
12.10
Research and Development to Revenue
2.25%
Intangibles to Total Assets
24.96%
Capex to Operating Cash Flow
-21.66%
Capex to Revenue
-5.67%
Capex to Depreciation
-362.94%
Stock-Based Compensation to Revenue
0.20%
Graham Number
2.73
Return on Tangible Assets
3.42%
Graham Net Net
-0.18
Working Capital
15,844,307
Tangible Asset Value
28,827,138
Net Current Asset Value
8,926,239
Average Receivables
21,072,531.5
Average Payables
692,756
Average Inventory
3,728,209.5
Days Sales Outstanding
126
Days Payables Outstanding
11
Days of Inventory On Hand
22
ROIC
6.37%
ROE
0.04%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
